1. Home
  2. ITRN vs ABUS Comparison

ITRN vs ABUS Comparison

Compare ITRN & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ituran Location and Control Ltd.

ITRN

Ituran Location and Control Ltd.

HOLD

Current Price

$59.85

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Arbutus Biopharma Corporation

ABUS

Arbutus Biopharma Corporation

HOLD

Current Price

$4.37

Market Cap

848.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ITRN
ABUS
Founded
1994
2005
Country
Israel
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
848.8M
IPO Year
2005
2008

Fundamental Metrics

Financial Performance
Metric
ITRN
ABUS
Price
$59.85
$4.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$60.67
$5.00
AVG Volume (30 Days)
99.9K
1.7M
Earning Date
05-26-2026
05-14-2026
Dividend Yield
3.61%
N/A
EPS Growth
N/A
55.26
EPS
N/A
0.87
Revenue
N/A
$14,083,000.00
Revenue This Year
$12.38
N/A
Revenue Next Year
$8.21
$239.71
P/E Ratio
$16.85
$5.10
Revenue Growth
N/A
128.21
52 Week Low
$32.71
$3.04
52 Week High
$62.31
$5.10

Technical Indicators

Market Signals
Indicator
ITRN
ABUS
Relative Strength Index (RSI) 61.69 50.92
Support Level $34.39 $4.17
Resistance Level $62.31 $4.60
Average True Range (ATR) 1.68 0.16
MACD -0.29 0.01
Stochastic Oscillator 58.81 61.46

Price Performance

Historical Comparison
ITRN
ABUS

About ITRN Ituran Location and Control Ltd.

Ituran Location and Control Ltd is a provider of location-based services. The company operates in two segments, namely Telematics services and Telematics products. The Telematics services segment consists of regionally-based stolen vehicle recovery (SVR) services, fleet management services, and value-added services comprised of personal locater services and concierge services. The Telematics product segment consists of short and medium-range two-way machine-to-machine wireless communications products that are used for various applications, including automatic vehicle location and automatic vehicle identification. Its geographical segments include Israel, Brazil, and Others. The company derives maximum revenue from Israel.

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes imdusiran (AB-729), a GalNAc-conjugated, subcutaneously delivered ribonucleic acid interference (RNAi) therapeutic, and AB-101, its proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

Share on Social Networks: